September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
ecancer – Ruben Mesa on Ropeginterferon’s Superiority in SURPASS-ET Trial
Jun 12, 2025, 10:33

ecancer – Ruben Mesa on Ropeginterferon’s Superiority in SURPASS-ET Trial

ecancer posted on X:

“The Phase 3 SURPASS-ET trial evaluates ropeginterferon alfa-2b versus anagrelide in patients with essential thrombocythaemia. Ropeginterferon shows superior safety and efficacy compared to anagrelide.
Watch full interview with Dr Ruben Mesa.”

More posts featuring Ruben Mesa.